Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GH Research PLC
GH Research Announces Global Pivotal Program Plans and Further Development Updates
July 23, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule
June 20, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Acceptance of Pharmaceutical Pipeline Presentation and Late-Breaking Posters at the American Society of Clinical Psychopharmacology 2025 Annual Meeting
May 15, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates
May 08, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates
February 27, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Pricing of $150 Million Public Offering
February 04, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Proposed Public Offering
February 03, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction
February 03, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research to Provide Update on Phase 2b Trial with GH001 in TRD
January 31, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Primary Endpoint Met in Two Phase 2a POC Trials with GH001 and Completion of All FDA Requests to Address IND Hold with No Findings of Respiratory Toxicity in Non-Rodents
January 10, 2025
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 14, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates
September 03, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer
September 03, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates
May 03, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
February 29, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Announces Grant of European Patent Covering all Mebufotenin (5-MeO-DMT) and Mebufotenin Salt Products For Use in the Treatment of Major Depressive Disorder and Treatment-Resistant Depression
January 18, 2024
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Third Quarter Financial Results and Provides Business Updates
November 09, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression
September 29, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates
August 23, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports First Quarter 2023 Financial Results and Provides Business Highlights
May 11, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Full Year 2022 Financial Results and Provides Business Updates
March 02, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Provides Business Updates and Highlights Key Upcoming Milestones
January 09, 2023
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
GH Research Reports Third Quarter 2022 Financial Results and Provides Business Updates
November 10, 2022
From
GH Research PLC
Via
GlobeNewswire
Tickers
GHRS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit